Rating Change
Wells Fargo analysts reiterated a Overweight rating on Amrize Ltd (NYSE:AMRZ) on July 08, 2026.
Rating Change Wells Fargo analysts reiterated a Overweight rating on Amrize Ltd (NYSE:AMRZ) on July 08, 2026. Market Context Amrize Ltd operates in the Basic Materials sector. The…

Wells Fargo analysts reiterated a Overweight rating on Amrize Ltd (NYSE:AMRZ) on July 08, 2026.
Amrize Ltd operates in the Basic Materials sector. The stock currently trades at $49.45 with a market capitalization of $35.9B. The stock has declined 0.5% over the past 52 weeks.
Analyst coverage from Wells Fargo provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Amrize Ltd.
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 8 Buy, 2 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 08, 2026 | Wells Fargo | Overweight | N/A |
| Jul 07, 2026 | Truist Securities | Hold | N/A |
| May 18, 2026 | Stephens & Co. | Overweight | N/A |
| May 04, 2026 | Citigroup | Buy | N/A |
| May 01, 2026 | Truist Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View AMRZ Stock Page
A Overweight rating from Wells Fargo reflects the analyst's outlook on Amrize Ltd (NYSE:AMRZ). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the AMRZ forecast page.
Current market data
NYSE · AMRZ
$43.70
Down: -$0.97 · -2.17%
Live quote updated
Keep reading